CytoSorbents Reports First Quarter 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Cytosorbents (CTSO) Misses Q1 EPS by 4c
May 2, 2023 4:19 PM EDTCytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $9.4 million versus the consensus estimate of $8.6 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More


